Identity
- Trade Name
- Zilver 635 FDA UDI
- Generic Name
- Peripheral artery stent, bare-metal FDA UDI
- Device Name
- Zilver 635 Vascular Stent FDA UDI
- Model / Reference
- G43865 FDA UDI
- Description
- Zilver 635 Vascular Stent FDA UDI
Identifiers
- Catalog Number
- ZIV6-35-80-10-30 FDA UDI
- Primary DI / UDI-DI
- 10827002438658 FDA UDI
- FDA Product Code
- NIO FDA UDI
- GMDN Term
- Peripheral artery stent, bare-metal FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Conditional FDA UDI
Category: Peripheral artery stent, bare-metal
Zilver 635 by Cook Ireland, Ltd. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Peripheral artery stent, bare-metal.
- Innova™ Vascular — Boston Scientific · Class III
- Pulsar-18 — Biotronik, Inc. · Class III
- LifeStent® Solo Vascular Stent — Bard Peripheral Vascular · Class III
- Astron — Biotronik, Inc. · Class III
- Absolute Pro — Abbott Vascular · Class III
- Protégé™ GPS™ — EV3, INC · Class II
- COMPLETE® SE VASCULAR — MEDTRONIC, INC. · Class III
- Supera™ — Abbott Vascular · Class III
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Cook Ireland, Ltd.
Sources (1)
- FDA UDI f87ed4aa-119a-4103-ba6a-22ccb2cb767d 36 fields · synced Jun 6, 2026